CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY

Trials shown by sponsor

Public title	Date of Registration	State
Phase I clinical trial for the evaluation of the therapeutic vaccine candidate Terap C.	2010-06-11	Registered
Phase I with CIGB-814 in rheumatoid arthritis patients	16/02/2017	Registered
Phase I/II clinical trial for the evaluation of vaccine candidate CIGB-230 in patients with chronic renal insufficiency.	2010-09-27	Registered
Phase II clinical trial for the evaluation of the therapeutic vaccine candidate Terap C.	2009-02-11	Registered
Quimi-Hib® and Quimi-Hib(AlPO4) vaccines in an accelerated 6-10-14 weeks primary vaccination series	2012-09-12	Registered
Reactogenicity and Immunogenicity of the pentavalent vaccine DPT-HB+Hib. Schedule 2-4-6 months.	2011-04-29	Registered
Reactogenicity and Immunogenicity of the pentavalent vaccine DPT-HB+Hib. Schedule 6-10-14 weeks.	2011-04-27	Registered
Recombinant IFN alpha-2b for relapsing –remitting multiple sclerosis.	2009-02-11	Registered
Recombinant interferon alpha-2b in paranoid schizophrenia.	2009-02-11	Registered
Retrospective observational study of the administration of Jusvinza, for the management of COVID-19 at the Hospital “Dr. Luis Diaz Soto”.	29/10/2021	Registered
Safety and immunogenicity of commercial Hepatitis B vaccines.	2009-02-27	Registered
Safety and immunogenicity of the CIGB 2020.	14/07/2020	Registered outdated
Safety and pharmacokinetics of CIGB-552	22/05/2015	Registered
Safety and Pharmacology of CIGB-300 in cervical cancer (CERVIFARM-300 Study)	2013-01-18	Registered
Safety with interferon in skin carcinomas (SCIENCE study)	2013-01-30	Registered
SOFIA Study	2011-05-24	Registered
Squamous cell carcinoma interferons (CECIN study)	2013-02-01	Registered
Study in Hematological Malignancies	14/11/2014	Registered
Teravac HIV in chronic HIV-1.	2011-08-10	Registered
THERESA	2008-10-07	Registered

Registered Trials

Registration process

CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY

About the RPCEC

Useful resources